)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
OSE Immunotherapeutics
OSE Immunotherapeutics (OSE) investor relations material
OSE Immunotherapeutics H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary29 Apr, 2026
Executive summary
Entered 2026 with a 3-year strategic roadmap focused on catalysts for lusvertikimab and Tedopi®.
Cash position was €22.7M at Dec 31, 2025, and €17.0M at Mar 31, 2026.
Cash runway expected to last until early Q4 2026.
Filing of the 2025 Universal Registration Document postponed to no later than May 28, 2026.
Financial highlights
2025 revenues were €2.6M, down from €69.9M in 2024, mainly due to non-recurring 2024 licensing and asset sales.
Operating income dropped to €2.7M in 2025 from €83.4M in 2024.
Net loss of €37.7M in 2025, compared to a net profit of €37.4M in 2024.
EPS was (€1.69) in 2025, down from €1.71 in 2024.
Cash and cash equivalents at Dec 31, 2025, were €17.6M, with total cash position at €22.7M.
Outlook and guidance
Cash runway sufficient until early Q4 2026, not including potential new financing or milestone payments.
Exploring options to extend runway: strategic partnerships, equity financing, debt restructuring, and milestone payments.
If no sufficient financing is secured, auditors may include a going concern qualification.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from OSE Immunotherapeutics
- Four value levers and EUR 90M funding drive a three-year plan with strong financial discipline.OSE
Investor Update11 Dec 2025 - Revenue and cash fell, funding secured to Q4 2026 amid milestone delays and financing risks.OSEH1 202516 Oct 2025
- Record H1 2024 income and clinical progress position OSE for sustained growth and innovation.OSEH1 202413 Jun 2025
- Record income and major partnerships fuel OSE Immunotherapeutics' profitable 2024.OSEH2 20245 Jun 2025
Next OSE Immunotherapeutics earnings date
H1 202628 Sep, 2026
OSE Immunotherapeutics
Next OSE Immunotherapeutics earnings date
H1 202628 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage